Acyclovir or Aβ42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells

NeuroReport

Volumn 21, Issue 14, 2010, Pages 922-927

  Lukiw, Walter J ^a   Cui, Jian Guo ^a   Yuan, Li Yuan ^a   Bhattacharjee, Partha S ^b   Corkern, Madelyn ^a   Clement, Christian ^a   Kammerman, Eli M ^a   Ball, M J ^c   Zhao, Yuhai ^d   Sullivan, Patrick M ^e   Hill, James M ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b XAVIER UNIVERSITY OF LOUISIANA   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e DUKE UNIVERSITY   (United States)

Author keywords

acyclovir; acyloguanosine; Alzheimer's disease; amyloid beta 42 peptide; herpes simplex virus type 1; inflammation; innate immune response; miRNA 146a

Indexed keywords

ACICLOVIR; AMYLOID BETA PROTEIN[1-42]; DNA POLYMERASE; MICRORNA; VIRUS DNA;

ALZHEIMER DISEASE; ARTICLE; BRAIN CELL; CONTROLLED STUDY; DRUG EFFECT; ENZYME INDUCTION; GLIA CELL; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; INNATE IMMUNITY; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; VIRUS CELL INTERACTION; VIRUS ENCEPHALITIS; VIRUS INHIBITION; VIRUS PLAQUE;

ACYCLOVIR; AMYLOID BETA-PEPTIDES; ANTIVIRAL AGENTS; CELLS, CULTURED; COCULTURE TECHNIQUES; DOWN-REGULATION; ENCEPHALITIS, HERPES SIMPLEX; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 1, HUMAN; HUMANS; MICRORNAS; NEUROGLIA; PEPTIDE FRAGMENTS; RNA, VIRAL; UP-REGULATION;

EID: 77956406669     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e32833da51a     Document Type: Article

References (25)

1. Whitley RJ, Roizman B. Herpes simplex virus. In: Richman DD, Whiley RJ, Hayden FG, editors. Clinical virology. Washington DC: ASM Press; 2009. pp. 409-436.
2. Toma HS, Murina AT, Areaux RG, Neumann DM, Bhattacharjee PS, Foster TP, et al. Ocular HSV-1 latency, reactivation and recurrent disease. Semin Ophthalmol 2008; 23:249-273.
3. Hill JM, Zhao Y, Clement C, Neumann DM, Lukiw WJ. HSV-1 infection of human brain cells induces miRNA-146a and Alzheimer-type inflammatory signaling. Neuroreport 2009; 20:1500-1505.
4. Ball MJ. Limbic predilection in Alzheimer dementia: is reactivated herpes virus involved? Can J Neurol Sci 1982; 9:303-306.
5. Wozniak MA, Itzhaki RF. Antiviral agents in Alzheimer's disease: hope for the future? Therapeutic Advances in Neurological Disorders 2010; 3:141-152.
6. Kammerman EM, Neumann DM, Ball MJ, Lukiw W, Hill JM. Senile plaques in Alzheimer's disease brains: possible association of beta-amyloid with herpes simplex virus type 1 (HSV-1) L-particles. Med Hypotheses 2006; 66:294-299.
7. Wozniak MA, Mee AP, Itzhaki RF. Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques. J Pathol 2009; 217:131-138.
8. Provost P. Micro-RNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases. Brain Res 2010; 1338:58-66.
9. Lukiw WJ. Micro RNA speciation in fetal, aged and Alzheimer hippocampus. Neuroreport 2007; 18:297-300.
10. Lukiw WJ, Zhao Y, Cui JG. An NF-kappaB-sensitive micro RNA-146amediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J Biol Chem 2008; 283:31315-31322.
11. Sethi P, Lukiw WJ. Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex. Neurosci Lett 2009; 459:100-104.
12. Lukiw WJ, Pogue AI. Induction of specific miRNA species by ROSgenerating metal sulfates in primary human brain cells. J Inorg Biochem 2007; 101:1265-1269.
13. Lagos D, Pollara G, Henderson S, Gratrix F, Fabani M, Milne RS, et al. miRNA-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nat Cell Biol 2010; 12:513-519.
14. Sonntag KC. MicroRNAs and deregulated gene expression networks in neurodegeneration. Brain Res 2010; 1338:48-57.
15. Bloom DC, Devi-Rao GB, Hill JM, Stevens JG, Wagner EK. Molecular analysis of HSV-1 during epinephrine-induced reactivation of latently infected rabbits in vivo. J Virol 1994; 68:1283-1292.
16. Kaufman HE, Azcuy AM, Varnell ED, Sloop GD, Thompson HW, Hill JM. HSV-1 DNA in tears and saliva of normal adults. Invest Ophthalmol Vis Sci 2005; 46:241-247.
17. Boehmer PE, Villani G. Herpes simplex virus type-1: a model for genome transactions. Prog Nucleic Acid Res Mol Biol 2003; 75:139-171.
18. Williams AE, Perry MM, Moschos SA, Larner-Svensson HM, Lindsay MA. Role of miRNA-146a in the regulation of the innate immune response. Biochem Soc Trans 2008; 36:1211-1215.
19. Li L, Chen XP, Li YJ. MicroRNA-146a and human disease. Scand J Immunol 2010; 71:227-231.
20. Hou J, Wang P, Lin L, Liu X, Ma F, An H, et al. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol 2009; 183:2150-2158.
21. Motsch N, Pfuhl T, Mrazek J, Barth S, Grässer FA. Epstein-Barr virusencoded latent membrane protein 1 (LMP1) induces the expression of the cellular miRNA-146a. RNA Biology 2007; 4:131-137.
22. Cullen BR. Viral and cellular messenger RNA targets of viral microRNAs. Nature 2009; 457:421-425.
23. Soscia SJ, Kirby JE,Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, et al. The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLos One 2010; 5:e9505.
24. Castellani RJ, Lee HG, Siedlak SL, Nunomura A, Hayashi T, Nakamura M, et al. Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta. J Alzheimer's Dis 2009; 18:447-452.
25. Mondragó n-Rodŕguez S, Basurto-Islas G, Lee HG, Perry G, Zhu X, Castellani RJ, et al. Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis. Expert Rev Neurother 2010 10:683-691.